No NCD payment obligations for Jul-Sep 2026 quarter

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+6.9%Reaction day

₹28.98

prior close

₹28.98

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%+5.5% vs market

Non Banking Financial Company (NBFC) peers, median of 222sector+0.0%+6.9% vs sector

On the reaction day the stock moved 5.5 pts more than Nifty Microcap 250 and 6.9 pts more than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+6.9+1.3+5.5+0.0+6.9

Next day

+0.1+1.1-1.0-0.4+0.5

+3.5-1.7+5.2-1.9+5.4

+5.2-1.5+6.7-1.2+6.4

+5.6-0.6+6.2-0.8+6.4

+8.9-0.4+9.3-0.4+9.3

+9.4-1.4+10.8-0.5+9.9

15d

+21.5pendingpending-3.9+25.4

—————

UpDownMarket · Nifty Microcap 250Sector · Non Banking Financial Company (NBFC) peers, median of 222Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Prism Medico and Pharmacy has filed a compliance certificate under SEBI LODR Regulation 57(5), confirming the company has not issued any non-convertible securities. As a result, there were no interest, dividend, or principal payment obligations due during the quarter from 1 July 2026 to 30 September 2026. This is a routine disclosure for companies without NCDs or similar instruments.

Likely market impact

Routine compliance filing. No financial impact as the company has no non-convertible securities outstanding.